Cell-penetrating peptides are a promising therapeutic strategy for a wide variety of degenerative diseases, ageing, and cancer. Among the multitude of cell-penetrating peptides, PepFect14 has been preferentially used in our laboratory for oligonucleotide delivery into cells and in vivo mouse models. However, this activity has mainly been reported towards cytoplasm and nuclei, while the mentioned disorders have been linked to mitochondrial defects. Here, we report a library generated from a combinatorial covalent fusion of a mitochondrial-penetrating peptide, mtCPP1, and PepFect14 in order to deliver therapeutic biomolecules to influence mitochondrial protein expression. The non-covalent complexation of these peptides with oligonucleotides resulted in nano-complexes affecting biological functions in the cytoplasm and on mitochondria. This delivery system proved to efficiently target mitochondrial genes, providing a framework for the development of mitochondrial peptide-based oligonucleotide technologies with the potential to be used as a treatment for patients with mitochondrial disorders.
Light‐triggered chemical reactions have demonstrated great potential for advanced cell guidance, on‐demand release of therapeutics, and complex patterning in four dimensions. Current strategies rely on the cleavage of a light sensitive bond, while several protein and therapeutic release systems are designed using a hydrolytically labile bond. To bridge the gap between externally controlled light regulated transformations and intrinsically controlled hydrolytically labile bonds, a new family of light‐triggered photocages that upon conjugation to target proteins form more or less hydrolytically (un)stable imine, hydrazone, and oxime bonds is reported. The three photocages follow a dose‐dependent relationship using ultraviolet and near‐infrared radiation and the one‐ and two‐photon uncaging can be controlled in discrete volumes down to at least 10 µm precision. Upon photoirradiation, the exposed latent amino‐, hydrazino‐, and hydroxylamino‐moieties readily react with a variety of proteins, and complimentary sustained release can be achieved. The relative release rate of imine‐, hydrazone‐, and oxime‐bound proteins enable control over cell fate on hydrogels using two neuroblastoma cell lines. These results are anticipated to open new avenues for advanced materials where region‐specifical degradability is central, such as for complex protein photopatterns, cell‐guided hydrogels, and for programmable materials using photomediated dynamic covalent chemistry and photoclick chemistry.